TY - JOUR
T1 - The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility
AU - Castaldi, Peter J.
AU - Cho, Michael H.
AU - Litonjua, Augusto A.
AU - Bakke, Per
AU - Gulsvik, Amund
AU - Lomas, David A.
AU - Anderson, Wayne
AU - Beaty, Terri H.
AU - Hokanson, John E.
AU - Crapo, James D.
AU - Laird, Nan
AU - Silverman, Edwin K.
PY - 2011/12/1
Y1 - 2011/12/1
N2 - Two recent metaanalyses of genome-wide association studies conducted by the CHARGE and SpiroMeta consortia identified novel loci yielding evidence of associationat or neargenome-wide significance (GWS) with FEV 1 and FEV 1/FVC. We hypothesized that a subset of these markers would also be associated with chronic obstructive pulmonary disease (COPD) susceptibility. Thirty-two single-nucleotide polymorphisms (SNPs) in or near 17 genes in 11 previously identified GWS spirometric genomic regions were tested for association with COPD status in four COPD case-control study samples (NETT/NAS, the Norway case-control study, ECLIPSE, and the first 1,000 subjects in COPDGene; total sample size, 3,456 cases and 1,906 controls). In addition to testing the 32 spirometric GWS SNPs, we tested a dense panel of imputed HapMap2 SNP markers from the 17 genes located near the 32 GWSSNPs and in a set of 21 well studiedCOPDcandidate genes. Of the previously identified GWS spirometric genomic regions, three loci harbored SNPs associated with COPD susceptibility at a 5% false discovery rate: the 4q24 locus including FLJ20184/ INTS12/GSTCD/NPNT, the 6p21 locus including AGER and PPT2, and the 5q33 locus including ADAM19. In conclusion, markers previously associated at or nearGWSwith spirometric measures were tested for association with COPD status in data from four COPD case-control studies, and three loci showed evidence of association with COPD susceptibility at a 5%false discovery rate.
AB - Two recent metaanalyses of genome-wide association studies conducted by the CHARGE and SpiroMeta consortia identified novel loci yielding evidence of associationat or neargenome-wide significance (GWS) with FEV 1 and FEV 1/FVC. We hypothesized that a subset of these markers would also be associated with chronic obstructive pulmonary disease (COPD) susceptibility. Thirty-two single-nucleotide polymorphisms (SNPs) in or near 17 genes in 11 previously identified GWS spirometric genomic regions were tested for association with COPD status in four COPD case-control study samples (NETT/NAS, the Norway case-control study, ECLIPSE, and the first 1,000 subjects in COPDGene; total sample size, 3,456 cases and 1,906 controls). In addition to testing the 32 spirometric GWS SNPs, we tested a dense panel of imputed HapMap2 SNP markers from the 17 genes located near the 32 GWSSNPs and in a set of 21 well studiedCOPDcandidate genes. Of the previously identified GWS spirometric genomic regions, three loci harbored SNPs associated with COPD susceptibility at a 5% false discovery rate: the 4q24 locus including FLJ20184/ INTS12/GSTCD/NPNT, the 6p21 locus including AGER and PPT2, and the 5q33 locus including ADAM19. In conclusion, markers previously associated at or nearGWSwith spirometric measures were tested for association with COPD status in data from four COPD case-control studies, and three loci showed evidence of association with COPD susceptibility at a 5%false discovery rate.
UR - http://www.scopus.com/inward/record.url?scp=82755165236&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=82755165236&partnerID=8YFLogxK
U2 - 10.1165/rcmb.2011-0055OC
DO - 10.1165/rcmb.2011-0055OC
M3 - Article
C2 - 21659657
AN - SCOPUS:82755165236
SN - 1044-1549
VL - 45
SP - 1147
EP - 1153
JO - American journal of respiratory cell and molecular biology
JF - American journal of respiratory cell and molecular biology
IS - 6
ER -